HealthPartners Institute | MedPath Search

Found 196 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "HealthPartners Institute"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Dementia With Lewy Bodies - Infinitome

Completed

Conditions: Dementia With Lewy Bodies

Interventions: Procedure: Infinitome

First Posted Date: 2021-02-26

Last Posted Date: 2024-11-01

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 91

Registration Number: NCT04773041

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

Impact of Colchicine and Low-dose Naltrexone on COVID-19

Phase 2

Completed

Conditions: Covid19

Interventions: Drug: Colchicine 0.6 mg
Drug: Naltrexone

First Posted Date: 2021-02-16

Last Posted Date: 2023-07-25

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 142

Registration Number: NCT04756128

Locations: 🇺🇸
Regions Hospital, Saint Paul, Minnesota, United States
🇺🇸
Park Nicollet Methodist Hospital, Saint Louis Park, Minnesota, United States

Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma

Phase 1

Terminated

Conditions: Uveal Melanoma

Interventions: Drug: PAC-1
Drug: Entrectinib

First Posted Date: 2020-10-19

Last Posted Date: 2023-11-22

Lead Sponsor: Arkadiusz Z. Dudek, MD

Target Recruit Count: 6

Registration Number: NCT04589832

Locations: 🇺🇸
HealthPartners Institute Regions Cancer Care Center, Minneapolis, Minnesota, United States

A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes

Phase 2

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: LY900014
Drug: Insulin Degludec

First Posted Date: 2020-10-14

Last Posted Date: 2022-06-03

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 31

Registration Number: NCT04585776

Locations: 🇺🇸
Atlanta Diabetes Associates, Atlanta, Georgia, United States
🇺🇸
Iowa Diabetes and Endocrinology Research Center, West Des Moines, Iowa, United States
🇺🇸
HealthPartners Institute dba International Diabetes Center, Minneapolis, Minnesota, United States

Effect of Prophylactic Negative Pressure Versus Silver Impregnated Silicone Bandage on C-Section Infection Rates

Completed

Conditions: D011247
D001458

Interventions: Device: silver impregnated dressing

First Posted Date: 2020-10-09

Last Posted Date: 2023-01-19

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 1064

Registration Number: NCT04582045

Locations: 🇺🇸
Regions Hospital, Saint Paul, Minnesota, United States

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Phase 2

Active, not recruiting

Conditions: Biliary Tract Neoplasms
Uterine Neoplasms
Urologic Neoplasms
Carcinoma, Non-Small-Cell Lung
HER2 Mutations Breast Neoplasms
Uterine Cervical Neoplasms

Interventions: Drug: tucatinib
Drug: trastuzumab
Drug: fulvestrant

First Posted Date: 2020-10-08

Last Posted Date: 2025-04-30

Lead Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Target Recruit Count: 217

Registration Number: NCT04579380

Locations: 🇺🇸
HealthPartners Institute, Saint Louis Park, Minnesota, United States
🇺🇸
Texas Oncology, P.A. - Dallas, Dallas, Texas, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 63 locations

Feasibility - Infinitome

Completed

Conditions: Alzheimer Disease

Interventions: Procedure: Infinitome

First Posted Date: 2020-09-24

Last Posted Date: 2021-02-17

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 4

Registration Number: NCT04563767

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

Acupuncture in Traumatic Brain Injury

Not Applicable

Completed

Conditions: Chronic Post-traumatic Headache
Mild Traumatic Brain Injury

Interventions: Procedure: Acupuncture

First Posted Date: 2020-04-30

Last Posted Date: 2025-01-27

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 39

Registration Number: NCT04369911

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

Phase 2

Terminated

Conditions: Lung Cancer
Non-small Cell Carcinoma

Interventions: Drug: Induction Durvalumab
Drug: Chemotherapy
Radiation: Radiation
Drug: Consolidation durvalumab

First Posted Date: 2020-04-27

Last Posted Date: 2024-12-20

Lead Sponsor: Rachel Sanborn

Target Recruit Count: 10

Registration Number: NCT04364048

Locations: 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
🇺🇸
HealthPartners Institute, Minneapolis, Minnesota, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

and more 2 locations

Post-Operative Cognitive Dysfunction in Normal Aging Patients Undergoing Elective Orthopedic Surgery

Completed

Conditions: Post Operative Cognitive Dysfunction

Interventions: Procedure: Elective Orthopedic Surgery

First Posted Date: 2020-02-12

Last Posted Date: 2024-04-19

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 47

Registration Number: NCT04267328

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States